Identification of the genomic region under epigenetic regulation during non‐alcoholic fatty liver disease progression

Abstract

Co-methylation and DMR analyses suggest that the NAFLD liver undergoes mitochondrial dysfunction, decreased lipid metabolism, and impaired oxidoreductase activity, and acquires tumorigenic potential at the epigenetic level.